Aspirin tablet

DRUG11 trials

Conditions

Acute Coronary SyndromeAngina, StableAtherosclerosisAtrial FibrillationBleedingBranch Atheromatous DiseaseCardiovascular DiseasesCerebral Infarction

Phase 1

The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction

SuspendedNCT03186456

Sclnow Biotechnology Co., Ltd.Cerebral Infarction

Start: 2025-12-31End: 2026-12-31Target: 40Updated: 2025-05-14

Phase 2

Postpartum Low-Dose Aspirin and Preeclampsia

RecruitingNCT03667326

Columbia UniversityPreeclampsia Postpartum

Start: 2019-07-22End: 2026-12-01Target: 100Updated: 2026-01-22

Aspirin for Prophylaxis of TTP

Not yet recruitingNCT05568147

The First Affiliated Hospital of Soochow UniversityThrombotic Thrombocytopenic Purpura

Start: 2022-10-01End: 2028-09-30Target: 100Updated: 2022-10-05

Phase 3

Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)

CompletedNCT06037889

Peking Union Medical College HospitalBranch Atheromatous Disease

Start: 2023-11-09End: 2026-02-26Updated: 2026-03-03

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

RecruitingNCT06082063

Steno Diabetes Center CopenhagenCardiovascular Diseases, Heart Failure, Kidney Failure +1

Start: 2024-07-01End: 2029-07-01Target: 2000Updated: 2025-01-10

Phase 4

Comparative Study Between Vaginal Progesterone Alone or Combined With Aspirin in Prevention of Recurrent Preterm Birth

CompletedNCT05319834

Menoufia UniversityPreterm Birth

Start: 2022-04-01End: 2023-12-31Updated: 2024-01-16

To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome

NCT05573958

Sarmad ZahoorAcute Coronary Syndrome

Start: 2022-10-01End: 2023-07-31Target: 90Updated: 2022-10-10

Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)

WithdrawnNCT06280976

University of LouisvilleAtherosclerosis, Coronary Artery Disease, Heart Attack

Start: 2024-03-01End: 2025-01-01Updated: 2025-03-17

Unknown Phase

Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin

NCT03306550

Xiyuan Hospital of China Academy of Chinese Medical SciencesAngina, Stable

Start: 2017-10-10End: 2018-10-10Target: 18Updated: 2017-10-11

Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation

NCT03821883

Xinhua Hospital, Shanghai Jiao Tong University School of MedicineAtrial Fibrillation, Bleeding, Stroke

Start: 2020-06-01End: 2024-12-01Target: 1120Updated: 2021-10-12

Molecular Effects of Aspirin & Metformin on Colonic Epithelium

WithdrawnNCT05158374

University of EdinburghColorectal Adenoma, Colorectal Cancer, Colorectal Neoplasms

Start: 2022-08-31End: 2023-06-30Updated: 2025-02-06

Related Papers

Efficacy and safety of tirofiban in patients with acute branch atheromatous disease-related stroke (BRANT): a protocol for a randomised controlled trial

BMJ Open2024-06-014 citations

Double-blind, placebo-controlled randomised clinical trial to evaluate the effect of ASPIRIN discontinuation after left atrial appendage occlusion in atrial fibrillation: protocol of the ASPIRIN LAAO trial

BMJ Open2021-03-013 citations

Drug-drug interactions between salvianolate injection and aspirin based on their metabolic enzymes.

2021-01-038 citations

Research on the mechanism of drug-drug interaction between salvianolate injection and aspirin based on the metabolic enzyme and PK-PD model: study protocol for a PK-PD trial.

2018-09-142 citations